PTGX Return on Tangible Equity | Protagonist Therapeutics, Inc

Protagonist Therapeutics, Inc (PTGX) Return on Tangible Equity

2026-06-30: Return Tang Equity 9.85%.
2026-03-31: Return Tang Equity -17.50%.
2025-12-31: Return Tang Equity -21.17%.
2025-09-30: Return Tang Equity 7.11%.

Complete source-backed return tang equity history.

Available history: 2014-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	9.85%
2026-03-31	-17.50%
2025-12-31	-21.17%
2025-09-30	7.11%
2025-06-30	7.79%
2025-03-31	8.16%
2024-12-31	40.75%
2024-09-30	32.12%
2024-06-30	31.40%
2024-03-31	28.93%
2023-12-31	-23.45%
2023-09-30	-46.49%
2023-06-30	-46.80%
2023-03-31	-64.85%
2022-12-31	-59.09%
2022-09-30	-53.41%
2022-06-30	-49.51%
2022-03-31	-40.59%
2021-12-31	-41.85%
2021-09-30	-32.62%
2021-06-30	-22.80%
2021-03-31	-27.02%
2020-12-31	-23.66%
2020-09-30	-38.19%
2020-06-30	-43.83%
2020-03-31	-132.71%
2019-12-31	-96.53%
2019-09-30	-77.13%
2019-06-30	-78.13%
2019-03-31	-44.99%
2018-12-31	-34.59%
2018-09-30	-22.68%
2018-06-30	-22.48%
2018-03-31	-26.62%
2017-12-31	-30.64%
2017-09-30	-78.07%
2017-06-30	-77.69%
2017-03-31	-52.78%
2016-12-31	-42.46%
2016-09-30	-32.23%
2016-06-30	60.14%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-21.17%
2024-12-31	40.75%
2023-12-31	-23.45%
2022-12-31	-59.09%
2021-12-31	-41.85%
2020-12-31	-23.66%
2019-12-31	-96.53%
2018-12-31	-34.59%
2017-12-31	-30.64%
2016-12-31	-42.46%
2015-12-31	54.23%
2014-12-31	87.73%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
TG THERAPEUTICS, INC. (TGTX)	United States	$8.805B	19.05
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
Praxis Precision Medicines, Inc. (PRAX)	United States	$7.884B	-27.60
Structure Therapeutics Inc. (GPCR)	United States	$7.710B	-53.41
Spyre Therapeutics, Inc. (SYRE)	United States	$7.685B	-43.69
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
Alkermes plc. (ALKS)		$6.844B	132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)	United States	$6.771B	-37.20